Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Micelle-Based Nanoparticles With Stimuli-Responsive Properties for Drug Delivery Publisher



Maboudi AH3 ; Lotfipour MH4 ; Rasouli M1, 2 ; Azhdari MH3 ; Macloughlin R5, 6, 7 ; Bekeschus S8, 9 ; Doroudian M3
Authors
Show Affiliations
Authors Affiliations
  1. 1. Plasma Medicine Group, Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Jalale-Al-Ahmad Ave, Tehran, 1411713137, Iran
  2. 2. Department of Physics, Kharazmi University, 49 Dr. Mofatteh Ave, Tehran, 15614, Iran
  3. 3. Department of Cell and Molecular Sciences, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
  4. 4. Department of Medical Genetics, School of Medicine, Babol University of Medical Sciences, Babol, Iran
  5. 5. Research and Development, Science and Emerging Technologies, Aerogen Limited, Galway Business Park, Galway, H91 HE94, Ireland
  6. 6. School of Pharmacy & Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, D02 YN77, Ireland
  7. 7. School of Pharmacy and Pharmaceutical Sciences, Trinity College, Dublin, D02 PN40, Ireland
  8. 8. ZIK Plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str 2, Greifswald, 17489, Germany
  9. 9. Clinic and Policlinic for Dermatology and Venerology, Rostock University Medical Center, Strempelstr. 13, Rostock, 18057, Germany

Source: Nanotechnology Reviews Published:2024


Abstract

Cancer treatment often causes adverse effects and toxicity, as chemotherapy drugs affect both cancerous and healthy cells. Scientists seek to target tumor cells specifically and minimize harm to normal cells. Smart nanoparticles (NPs) are a modern technique that can release drugs when triggered by internal or external stimuli, such as temperature, pH, ultrasound, etc. This review covers stimuli-responsive micelle-based nanoparticles (SRM-NPs), a promising drug delivery platform that can enhance drug efficacy and reduce toxicity. It discusses the recent developments and applications of SRM-NPs, their responsiveness to different stimuli, and their potential to overcome drug resistance and adaptive responses. It also addresses the challenges and issues related to their stability, reproducibility, biocompatibility, safety, and optimization. The study concludes that SRM-NPs have great potential for drug delivery, but more research and development are needed to improve their clinical utility. © 2024 the author(s), published by De Gruyter.
Other Related Docs
12. Encapsulation: Controlled Drug Delivery, Principles of Biomaterials Encapsulation: Volume 2 (2023)
15. Critical Parameters to Translate Gold Nanoparticles As Radiosensitizing Agents Into the Clinic, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2023)
17. Nonviral Sirna Delivery Systems for Pancreatic Cancer Therapy, Biotechnology and Bioengineering (2021)
24. Biomedical Applications of Intelligent Nanomaterials, Intelligent Nanomaterials: Second Edition (2016)
27. Commercial and Regulatory Challenges in Cancer Nanomedicine, Functionalized Nanomaterials for Cancer Research: Applications in Treatments# Tools and Devices (2024)
33. Recent Advances on the Application of Nanobiomimetic Structures As Drug Delivery Systems, Journal of Drug Delivery Science and Technology (2024)
34. A Concise Review on Cancer Treatment Methods and Delivery Systems, Journal of Drug Delivery Science and Technology (2019)
35. Nano-Particles’ Benefits for Colon Cancer Effective Therapy: A Review of Recent Advancements and Clinical Trials, International Journal of Polymeric Materials and Polymeric Biomaterials (2024)
36. The Use of Nanoparticles As a Promising Therapeutic Approach in Cancer Immunotherapy, Artificial Cells# Nanomedicine and Biotechnology (2016)
38. Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery, Smart External Stimulus-Responsive Nanocarriers for Drug and Gene Delivery (2015)
44. An Update on Nanoparticle-Based Contrast Agents in Medical Imaging, Artificial Cells# Nanomedicine and Biotechnology (2018)
49. Ph-Sensitive Stimulus-Responsive Nanocarriers for Targeted Delivery of Therapeutic Agents, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2016)